» Articles » PMID: 2444902

Selective Agonists for Substance P and Neurokinin Receptors

Overview
Journal Neuropeptides
Publisher Elsevier
Specialties Biochemistry
Neurology
Date 1987 Jul 1
PMID 2444902
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

A series of neurokinin analogues and fragments have been prepared in an attempt to identify selective agonists for NK-P, NK-A and NK-B receptors. The compounds have been tested on the dog carotid artery (NK-P receptor system), the rabbit pulmonary artery (NK-A) and the rat portal vein (NK-B). C-terminal substituted analogues of the three neurokinins have provided indication that NK-P receptor selectivity is improved by the oxidation of methionine to Met(O2), while selectivity for NK-A is favoured by replacing Met with NIe. Selectivity for NK-P receptors is further improved by the replacement of Gly9 with Sar. Selectivity and affinity for NK-B receptors is markedly increased when Val7 is replaced with MePhe in both the fragment NKB (4-10) and NKB. The results of the present study indicate that a) [Sar9,Met(O2)11]SP is a potent and selective agonist for the NK-P receptors of the dog carotid artery; b) [MePhe7]NKB is a very potent and selective stimulant of receptors for neurokinin B and c) [Nle10]NKA (4-10) is a promising compound, showing some selectivity for NK-A receptor; further modifications are however needed to improve its affinity.

Citing Articles

Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi,Met(O)]-Substance P.

Suthiram J, Pieters A, Mohamed Moosa Z, Zeevaart J, Sathekge M, Ebenhan T Int J Mol Sci. 2023; 24(3).

PMID: 36768456 PMC: 9916806. DOI: 10.3390/ijms24032134.


Neurokinin-3 receptor activation selectively prolongs atrial refractoriness by inhibition of a background K channel.

Veldkamp M, Geuzebroek G, Baartscheer A, Verkerk A, Schumacher C, Suarez G Nat Commun. 2018; 9(1):4357.

PMID: 30341287 PMC: 6195571. DOI: 10.1038/s41467-018-06530-5.


Targeting neurokinin-3 receptor: a novel anti-angiogenesis strategy for cancer treatment.

Wang T, Chen S, Wang S, Shi L, Wang C, Zhang J Oncotarget. 2017; 8(25):40713-40723.

PMID: 28489574 PMC: 5522309. DOI: 10.18632/oncotarget.17250.


Endothelin-converting enzyme 1 and β-arrestins exert spatiotemporal control of substance P-induced inflammatory signals.

Jensen D, Halls M, Murphy J, Canals M, Cattaruzza F, Poole D J Biol Chem. 2014; 289(29):20283-94.

PMID: 24898255 PMC: 4106342. DOI: 10.1074/jbc.M114.578179.


Effects of neurokinin B administration on reproductive hormone secretion in healthy men and women.

Jayasena C, Comninos A, de Silva A, Abbara A, Veldhuis J, Nijher G J Clin Endocrinol Metab. 2013; 99(1):E19-27.

PMID: 24170109 PMC: 3952021. DOI: 10.1210/jc.2012-2880.